BioMarin to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 21 at 4:30pm ET

SAN RAFAEL, Calif., Jan. 23, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February 21, at 4:30 p.m. ET to discuss fourth quarter and full year 2018 financial results and provide a general business update.

Dial-in Number U.S. / Canada Dial-in Number: (866) 502-9859International Dial-in Number: (574) 990-1362Conference ID: 8265006

Replay Dial-in Number: (855) 859-2056Replay International Dial-in Number: (404) 537-3406Conference ID: 8265006

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com.  A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com.  

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2018-financial-results-conference-call-and-webcast-on-thursday-february-21-at-430pm-et-300782577.html

SOURCE BioMarin Pharmaceutical Inc.